About

About UK Health Security Agency Come and talk to us at the UK Pavilion (765) about how we can help support your research and development requirements with consultancy and assay development from our world-renowned experts, our wide range of specialist services and diagnostics, our high containment facilities and our ability to provide high throughput laboratory analysis capacity. The UK Health Security Agency (UKHSA) is responsible for planning, preventing and responding to external health threats, and providing intellectual, scientific and operational leadership at national and local level, as well as globally. We are an executive agency, sponsored by the Department of Health and Social Care. The Agency operates a network of laboratories across England including centres of excellence at Colindale (London) and Porton (Wiltshire), providing a range of clinical, reference and public health microbiology services including bacteriology, mycology, virology, immunology, and genomics. Leadership in communicable diseases, field epidemiology and rapid investigations is also supported by real-time surveillance and analysis and emergency preparedness and response activities delivered via regional health protection teams. All our laboratories have active research and development interests, including the evaluation of novel vaccines, antimicrobials, and in vitro diagnostics, and all our clinical laboratories can assist with access to clinical samples, including novel and emerging pathogens. Our key services include conducting 4 million regional laboratory tests, analysing 350,000+ reference samples, performing 190,000 genomic sequences annually, handling 40,000 rare pathogen referrals, and processing 500,000 radiation dosimeters yearly. We also offer advanced diagnostic capabilities, world-leading expertise in vaccine evaluation and phage translation/application, and have one of the strongest behavioural science units in UK Government. We employ 3,000 scientists across 30+ disciplines and we maintain strong partnerships with 500+ universities globally. Our intellectual property portfolio includes 165 patents and 64 trademarks. UKHSA’s unique position as a public health organisation combines scientific expertise, laboratory infrastructure, and research capabilities. Our income generated from commercial services strengthens our core health security work, while our collaborative approach with industry and academia drives public health benefits and economic growth. We provide a comprehensive range of specialist health security services and products, addressing challenges in public health protection and disease surveillance. These consist of a range of clinical, reference and public health microbiology services including bacteriology, mycology, virology, immunology, and genomics. Leadership in communicable diseases, field epidemiology and rapid investigations is also supported by real-time surveillance and analysis and emergency preparedness and response activities delivered via regional health protection teams. Our key services include: Radiation personal dosimetry service (processing ~500,000 dosimeters annually) Regional laboratory testing (4 million tests supporting NHS diagnostics and public health outbreaks) Reference services (350,000+ samples for specific pathogen analysis) Genomic sequencing (90,000 next-generation and 100,000 Sanger sequencing samples annually) Rare and Imported Pathogen Laboratory services (40,000 NHS referrals) UKHSA's competitive advantages include: One of the strongest behavioural science and insights functions in UK Government Employment of 3,000 scientists across 30+ scientific disciplines Extensive intellectual property portfolio (165 patents and 64 registered trademarks) Strong partnerships with academia (500+ universities globally) Advanced diagnostic capabilities and accelerator programme World-leading expertise in phage translation and application High containment facilities for in vivo and in vitro research (BSL 3 and 4) Our value proposition lies in our unique position as a public health organisation combining scientific expertise, extensive laboratory infrastructure, and research capabilities. The income generated from commercial services strengthens our core health security services, while our collaborative approach with industry and academia drives both public health benefits and economic growth. Come and talk to us at the UK Pavilion (765) about how we can help support your research and development requirements with consultancy and assay development from our world-renowned experts, our wide range of specialist services and diagnostics, our high containment facilities and our ability to provide high throughput laboratory analysis capacity. The UK Health Security Agency (UKHSA) is responsible for planning, preventing and responding to external health threats, and providing intellectual, scientific and operational leadership at national and local level, as well as globally. We are an executive agency, sponsored by the Department of Health and Social Care. The Agency operates a network of laboratories across England including centres of excellence at Colindale (London) and Porton (Wiltshire), providing a range of clinical, reference and public health microbiology services including bacteriology, mycology, virology, immunology, and genomics. Leadership in communicable diseases, field epidemiology and rapid investigations is also supported by real-time surveillance and analysis and emergency preparedness and response activities delivered via regional health protection teams. All our laboratories have active research and development interests, including the evaluation of novel vaccines, antimicrobials, and in vitro diagnostics, and all our clinical laboratories can assist with access to clinical samples, including novel and emerging pathogens. Our key services include conducting 4 million regional laboratory tests, analysing 350,000+ reference samples, performing 190,000 genomic sequences annually, handling 40,000 rare pathogen referrals, and processing 500,000 radiation dosimeters yearly. We also offer advanced diagnostic capabilities, world-leading expertise in vaccine evaluation and phage translation/application, and have one of the strongest behavioural science units in UK Government. We employ 3,000 scientists across 30+ disciplines and we maintain strong partnerships with 500+ universities globally. Our intellectual property portfolio includes 165 patents and 64 trademarks. UKHSA’s unique position as a public health organisation combines scientific expertise, laboratory infrastructure, and research capabilities. Our income generated from commercial services strengthens our core health security work, while our collaborative approach with industry and academia drives public health benefits and economic growth. We provide a comprehensive range of specialist health security services and products, addressing challenges in public health protection and disease surveillance. These consist of a range of clinical, reference and public health microbiology services including bacteriology, mycology, virology, immunology, and genomics. Leadership in communicable diseases, field epidemiology and rapid investigations is also supported by real-time surveillance and analysis and emergency preparedness and response activities delivered via regional health protection teams. Our key services include: Radiation personal dosimetry service (processing ~500,000 dosimeters annually) Regional laboratory testing (4 million tests supporting NHS diagnostics and public health outbreaks) Reference services (350,000+ samples for specific pathogen analysis) Genomic sequencing (90,000 next-generation and 100,000 Sanger sequencing samples annually) Rare and Imported Pathogen Laboratory services (40,000 NHS referrals) UKHSA's competitive advantages include: One of the strongest behavioural science and insights functions in UK Government Employment of 3,000 scientists across 30+ scientific disciplines Extensive intellectual property portfolio (165 patents and 64 registered trademarks) Strong partnerships with academia (500+ universities globally) Advanced diagnostic capabilities and accelerator programme World-leading expertise in phage translation and application High containment facilities for in vivo and in vitro research (BSL 3 and 4) Our value proposition lies in our unique position as a public health organisation combining scientific expertise, extensive laboratory infrastructure, and research capabilities. The income generated from commercial services strengthens our core health security services, while our collaborative approach with industry and academia drives both public health benefits and economic growth.